GenScript USA Inc.
- GenScript was founded in 2002 in New Jersey, U.S.
- GenScript started to provide comprehensive gene services in 2002.
- GenScript (Nanjing) subsidiary was established in 2004.
- GenScript initiated custom protein services in 2004.
- GenScript began custom peptide services in 2004.
- GenScript started ofering custom antibody services in 2005.
- GenScript became the largest gene synthesis supplier in the U.S. in 2008.
- GenScript began to offer a comprehensive portfolio of CRO services that include Bio-reagent, Bio-assay, Lead Optimization, and Antibody Drug Development in 2008.
- GenScript antibody services guarantees were regarded as the best in the industry in 2008.
- GenScript became the largest biology CRO in China following major capacity and capability upgrade in 2009.
- GenScript animal facility received AAALAC accreditation in 2009.
- GenScript received $15M venture capital investment from KPCB and TBIG Healthcare in 2009.
Project-based
- Clearly defined process and deliverables
- Short-term and long-term engagements with option to renew
- Cost saving schemes available
FTE-Based
- Dedicated professional team
- Expert-on-demand services for maximum flexibility
- Great resource savings
Strategic Alliance
- Risk-sharing and win-win strateg
- Clearly defined milestones and payment schedule
- Streamlined resource and profit allocation